0010.HK HKSE
Hang Lung Group Limited
1W: +0.5%
1M: -1.9%
3M: -7.0%
YTD: -27.6%
1Y: -15.3%
3Y: +18.1%
5Y: -16.6%
HK$12.14 ($1.55)
-0.18 (-1.46%)
Weekly Expected Move ±2.5%
HK$12
HK$12
HK$12
HK$12
HK$13
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$10.4B
-11.4% ▼
5Y CAGR: +1.7%
Gross Profit
$6.7B
-2.0% ▼
5Y CAGR: -0.6%
Operating Income
$6.2B
+0.0% ▲
5Y CAGR: -0.6%
Net Income
$1.4B
-15.1% ▼
EPS (Diluted)
$1.01
-14.4% ▼
EBITDA
$6.3B
+21.1% ▲
5Y CAGR: -0.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10.9B | $10.9B | $11.0B | $11.8B | $10.4B |
| YoY Growth | +14.4% | +0.0% | +0.7% | +6.8% | -11.4% |
| Cost of Revenue | $3.1B | $3.3B | $3.1B | $4.9B | $3.7B |
| Gross Profit | $7.8B | $7.7B | $7.9B | $6.8B | $6.7B |
| Gross Margin | 71.5% | 70.2% | 72.0% | 58.0% | 64.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $618M | $673M | $680M | $672M | $0 |
| Operating Expenses | $589M | $662M | $675M | $665M | $527M |
| Operating Income | $7.2B | $7.0B | $7.2B | $6.2B | $6.2B |
| Operating Margin | 66.0% | 64.2% | 65.8% | 52.4% | 59.2% |
| Interest Expense | $430M | $449M | $623M | $846M | $0 |
| Income Before Tax | $7.3B | $6.4B | $6.6B | $4.3B | $4.1B |
| Tax Expense | $2.2B | $1.6B | $1.7B | $1.4B | $1.7B |
| Net Income | $2.6B | $2.7B | $2.8B | $1.6B | $1.4B |
| Net Margin | 23.7% | 24.9% | 25.5% | 13.7% | 13.2% |
| EPS (Diluted) | $1.90 | $2.00 | $2.06 | $1.18 | $1.01 |
| EBITDA | $7.3B | $7.1B | $7.2B | $5.2B | $6.3B |
| Shares Outstanding | 1.36B | 1.36B | 1.36B | 1.36B | 1.36B |